INTERCEPT PHARMACEUTICALS IN ICPT 3.5 02.15.26
NOTE 3.500% 2/1 · US DOMESTIC · CUSIP 45845PAC2
7
institutional holders
+0 vs Q1 2023
60.0k
shares reported held*
$106.4mreported value*
0 new
0 added
0 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1773.11.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 11 |
| Q4 2022 | 11 |
| Q1 2023 | 7 |
| Q2 2023 | 7 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 4 | 4 |
| Q1 2023 | 2 | 6 |
| Q2 2023 | 0 | 0 |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. 2.01% of their portfolio | 98.4m $94.0m | Unchanged |
| WOLVERINE ASSET MANAGEMENT LLC 0.14% of their portfolio | 7.8m $7.5m | Unchanged |
| Graham Capital Management, L.P. 0.15% of their portfolio | 4.5m $4.3m | Unchanged |
| CITIGROUP INC 0.00% of their portfolio | 262.0k $245.8k | Unchanged |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 175.0k $170.6k | Unchanged |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 60.0k $55.6k | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |